Literature DB >> 16110586

Q fever and the US military.

Alicia D Anderson, Bonnie Smoak, Eric Shuping, Christopher Ockenhouse, Bruno Petruccelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16110586      PMCID: PMC3320491          DOI: 10.3201/eid1108.050314

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Q fever is a zoonotic disease caused by the rickettsialike organism Coxiella burnetii. The disease has a worldwide distribution and can infect many different species, although cattle, sheep, and goats are the primary reservoirs (1). Transmission to humans usually occurs by inhaling dust or aerosols from infected animals, and approximately half of infected persons manifest clinical symptoms. In acute Q fever infection, the 3 main sets of symptoms are flulike syndrome, pneumonia, and hepatitis (2,3). Q fever has military relevance not only in its potential use as a bioterrorism agent, but also because of the risk for natural infection in deployed military personnel. Thousands of cases of Q fever have been seen in military personnel since the disease was first reported in the 1930s (4). Since the most common mode of transmission is airborne, personnel do not need to have direct contact with infected animals to be exposed. C. burnetii was first recognized as an infectious disease threat to US military troops serving in Iraq in 2003 during a pneumonia outbreak investigation. Nineteen cases of severe pneumonia, including 2 deaths, occurred from March 1 to August 20 (5). A case was defined as occurring in a patient with bilateral alveolar infiltrates that required intubation and mechanical ventilation. This investigation involved extensive serologic testing for possible infectious causes of pneumonia, including C. burnetii. Of 19 patients with severe pneumonia tested for C. burnetii, 3 had positive antibody titers by immunofluorescence assay (IFA). No other infectious cause was confirmed for the remaining cases of pneumonia. Although C. burnetii was not determined to be the cause of the pneumonia outbreak, the finding of 3 patients with positive antibody titers launched an effort to ascertain other cases of Q fever among military personnel who served in Iraq during that time. Approximately 62 cases of pneumonia, both severe and nonsevere, occurred in Iraq from March 1 to August 20, 2003. A pneumonia case was defined as occurring in a patient with a chest radiograph suggesting pneumonia and ≥1 of the following symptoms: fever, cough, or shortness of breath. The Defense Medical Surveillance System (DMSS) was queried to determine how many patients had both predeployment and postdeployment serum samples available for Q fever testing. The Army Medical Surveillance Activity, which operates DMSS, also maintains the Department of Defense Serum Repository and stores serum from service members after mandatory HIV testing and deployment processing (6). Predeployment sera must be collected within the year before deployment. Twenty-two soldiers had predeployment and postdeployment sera available; samples were tested for phase I and phase II antibody to Q fever by using IFA. Results showed 5 additional soldiers in whom pneumonia was diagnosed while serving in Iraq and who seroconverted to C. burnetii before postdeployment serum draws (Table). All predeployment antibody titers for both immunoglobulin (Ig) G and IgM were negative in these 5 soldiers, with an IFA titer of 1:16 as a cutoff.
Table

Postdeployment serum antibody titers to phase II antigen for Q fever in 8 US military personnel who served in Iraq, March 1–August 20, 2003*

PatientIgGIgM
11:1,024Negative
21:128Negative
3>1:1,0241:512
41:2561:256
51:512>1:1,024
61:5121:512
71:641:64
8>1:1,024>1:1,024

*All predeployment titers were negative for immunoglobulin (Ig) G and IgM.

*All predeployment titers were negative for immunoglobulin (Ig) G and IgM. The initial 3 Q fever patients ascertained through the pneumonia outbreak investigation were extensively interviewed for possible exposures. All 3 patients first experienced symptoms while in northern Iraq and reported contact with domestic animals, including dogs, cats, sheep, goats, and camels. Two of the patients reported tick bites within 30 days before becoming ill, and 1 reported drinking raw sheep's milk. The 5 other patients who became ill with pneumonia also first sought care while in northern Iraq. Predeployment sera from these 3 patients were also tested for C. burnetii by IFA, and all samples were negative for both IgG and IgM. Extremely limited information is available on Q fever disease prevalence in Iraq, either in animals or humans. Iraq is primarily an agricultural country, and nomadic herding takes place countrywide, except in the northernmost regions and along the eastern border, where adequate land is available for grazing livestock. The most common livestock in Iraq are cattle, sheep, and goats (7). Although herds of infected animals may exist in any region of Iraq, larger concentrations of livestock may exist in northern areas, where land is suitable for ruminants to graze. This concentration could lead to a higher risk for transmission to humans because the chance of contact with infected animals would be greater. These data indicate the potential importance of C. burnetii as an infectious disease threat to US military troops in Iraq. Healthcare providers should include Q fever in their differential diagnosis of community-acquired pneumonia and consider adding doxycycline to a combined antimicrobial drug regimen to presumptively treat severe pneumonia. Future studies to be completed include case ascertainment to locate US troops who were infected with Q fever while in Iraq and in whom pneumonia or other clinical manifestations of illness may have developed. Research was conducted in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to principles stated in the Guide for the Care and Use of Laboratory Animals, NRC Publication, 1996 edition.
  6 in total

Review 1.  The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance.

Authors:  Mark V Rubertone; John F Brundage
Journal:  Am J Public Health       Date:  2002-12       Impact factor: 9.308

2.  The spread of Q fever from animals to man; the natural history of a rickettsial disease.

Authors:  M G STOKER; B P MARMION
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

3.  Severe acute pneumonitis among deployed U.S. military personnel--Southwest Asia, March-August 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-09-12       Impact factor: 17.586

Review 4.  Q fever.

Authors:  M Maurin; D Raoult
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

5.  Q fever in humans and animals in the United States.

Authors:  Jennifer H McQuiston; James E Childs
Journal:  Vector Borne Zoonotic Dis       Date:  2002       Impact factor: 2.133

6.  Military significance of Q fever: a review.

Authors:  A J Spicer
Journal:  J R Soc Med       Date:  1978-10       Impact factor: 18.000

  6 in total
  15 in total

1.  Seroepidemiologic survey for Coxiella burnetii among US military personnel deployed to Southwest and Central Asia in 2005.

Authors:  Joseph Royal; Mark S Riddle; Emad Mohareb; Marshall R Monteville; Chad K Porter; Dennis J Faix
Journal:  Am J Trop Med Hyg       Date:  2013-09-16       Impact factor: 2.345

2.  Application of a broad-range resequencing array for detection of pathogens in desert dust samples from Kuwait and Iraq.

Authors:  Tomasz A Leski; Anthony P Malanoski; Michael J Gregory; Baochuan Lin; David A Stenger
Journal:  Appl Environ Microbiol       Date:  2011-05-13       Impact factor: 4.792

3.  Molecular Identification of Q Fever in Patients with a Suspected Diagnosis of Dengue in Brazil in 2013-2014.

Authors:  Maria Angélica M M Mares-Guia; Tatiana Rozental; Alexandro Guterres; Michelle Dos Santos Ferreira; Renato De Gasperis Botticini; Ana Kely Carolina Terra; Sandro Marraschi; Rosany Bochner; Elba R S Lemos
Journal:  Am J Trop Med Hyg       Date:  2016-02-29       Impact factor: 2.345

Review 4.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

5.  Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.

Authors:  Javier Ochoa-Repáraz; Jami Sentissi; Theresa Trunkle; Carol Riccardi; David W Pascual
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

Review 6.  Gulf war servicemen and servicewomen: the long road home and the role of health care professionals to enhance the troops' health and healing.

Authors:  Robin B McFee
Journal:  Dis Mon       Date:  2008-05       Impact factor: 3.800

7.  Serosurvey and observational study of US Army Veterinary Corps officers for Q fever antibodies from 1989 to 2008.

Authors:  K G Vest; L L Clark
Journal:  Zoonoses Public Health       Date:  2013-07-17       Impact factor: 2.702

Review 8.  Description and utilization of the United States department of defense serum repository: a review of published studies, 1985-2012.

Authors:  Christopher L Perdue; Angelia A Eick Cost; Mark V Rubertone; Luther E Lindler; Sharon L Ludwig
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

9.  Detection of Q Fever Specific Antibodies Using Recombinant Antigen in ELISA with Peroxidase Based Signal Amplification.

Authors:  Hua-Wei Chen; Zhiwen Zhang; Erin Glennon; Wei-Mei Ching
Journal:  Int J Bacteriol       Date:  2014-03-12

10.  Atypical Q fever in US soldiers.

Authors:  Joshua D Hartzell; Suzette W Peng; Robert N Wood-Morris; Dennis M Sarmiento; Jacob F Collen; Paul M Robben; Kimberly A Moran
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.